Serum Growth Differentiation Factor-15/Albumin Ratio as a 2-Year Survival Marker of End-Stage Renal Disease Patients Initiating Maintenance Hemodialysis. This evidence concerns the gene GDF15 and stage 5 chronic kidney disease.